Subacute Cutaneous Lupus Erythematosus
Razit may cause subacute cutaneous lupus
erythematosus, lesion and pain
in a joints (arthralgia). Immediate medical help and discontinuation of proton pump inhibitors should be considered on the occurrence of lesions and pain in joints (arthralgia).
Interference With Laboratory Tests
Increased Chromogranin A (protein) level may interfere with the test for both neural and endocrine cancer
). To avoid this interference, Razit should be discontinued for at least 5 days before chromogranin A measurements.
Stomach And Intestinal Infection
Patients who are taking Razit are at an increased risk. Razit increases the count of bacteria in the stomach and intestine. It may increase the risk of infection caused by Salmonella
and Clostridium difficile.
Use With Methotrexate
When Razit is used with methotrexate, it may increase the level of methotrexate in the blood. In case of high dose intake of methotrexate, a temporary withdrawal of Razit should be considered.
Patients on prolonged treatment (at least three months or years) or who are taking Razit with digoxin or may cause the deficiency of magnesium are at an increased risk. This may cause harmful effects like seizures
, muscle spasm, increase or decrease in heartbeat, dizziness
, disturbance in mental abilities and fatigue
. Treatment of low magnesium level in the blood can be improved by magnesium replacement or discontinuation of Razit.
Patients with bone weakness related fractures
are at an increased risk when using Razit for the longer period of time or taking its high doses. Long-term use or high doses of Razit may increase the risk of fractures of the wrist, hip, or spine. Patients with bone weakness related fractures should take the lowest dose of Razit for the shorter duration of time. Also, patients should have an adequate intake of calcium
Bacteria (Clostridium difficile) Associated Diarrhea
Patients who are taking Razit are at an increased risk. The use of Razit with clarithromycin or amoxicillin may cause bacteria associated diarrhea
. Patients with bacteria associated diarrhea should take the lowest dose of Razit for short period of time.
Vitamin B-12 Deficiency
Patients who are taking Razit are at an increased risk. Long-term (more than 3 years) use of acid-suppressing agents may lead to vitamin
B-12 deficiency due to the absence of hydrochloric acid in the stomach. Diagnosis should be considered if these clinical symptoms persist.
Inflammation Within The Kidneys
Patients who are taking Razit are at an increased risk. Razit may cause inflammation in the kidneys which lead to unknown harmful allergic reactions in the body. If a patient develops inflammation in the kidneys, discontinue the use of Razit.
Use With Warfarin
Use of Razit with warfarin increases the levels of blood parameters such as blood clotting time which may lead to abnormal bleeding
and may cause a fatality. Blood parameters should be monitored in patients taking Razit with warfarin.
Stomach Cancer (Gastric Malignancy)
Treatment with Razit does not prevent the presence of stomach ulcers
in these patients.
Use In Combination With Antibacterial Agents
Patients who are allergic to antibacterial agents (clarithromycin and amoxicillin) should take precaution when using with Razit.